UB Cancer Research Consortium

The University at Buffalo Cancer Research Consortium is a collaborative effort that recognizes the critical value of multi-disciplinary collaborative science and diversity towards the goal of facilitating opportunities for grants for basic and clinical translation science.

About the Consortium

The University at Buffalo Cancer Research Consortium seminar series provides a platform to achieve the central goal of the Consortium. It is a multi-disciplinary group that brings together physicians, physician-scientists, scientists, pathologists, postdoctoral fellows and medical and graduate students with a convergent interest in translational cancer research, establishment of team science grant applications and facilitating the translation of basic research findings into the clinical setting.

Mission Priorities

  • To serve our diverse and socio economically disadvantaged communities
  • To promote cancer health equity, access to cancer care and cutting-edge clinical trial testing 
  • To study the genomic, epigenomic, environmental and behavioral factors contributing to cancer in WNY

Vision

The UB Cancer Research Consortium and GLCCC will be a research hub for the SUNY system for personalized care and scientific discovery focused on the unique population of WNY, a blend of minorities including African Americans, Hispanics, Native Americans and refugees' communities.

Cancer Research Pillars at UB

  1. Epidemiology, prevention and early detection 
  2. Drug discovery and development 
  3. Drug toxicities and therapeutic interventions
  • > 100 active cancer awards (18 R01 - 9 new; 4 R21s)    
  • 39 investigators
  • 20 departments
  • 6 schools